| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
Cytidine, 2'-deoxy-3-methyl- manufacturers
|
| | Cytidine, 2'-deoxy-3-methyl- Basic information |
| Product Name: | Cytidine, 2'-deoxy-3-methyl- | | Synonyms: | Cytidine, 2'-deoxy-3-methyl-;2'-Deoxy-N3-methylcytidine;2'-deoxy-3-methyl-cytidine;N3-Me-2'-dC;2’-Deoxy-N3-methylcytidine;1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-imino-3-methyl-3,4-dihydropyrimidin-2(1H)-one | | CAS: | 5040-21-1 | | MF: | C10H15N3O4 | | MW: | 241.24 | | EINECS: | | | Product Categories: | | | Mol File: | 5040-21-1.mol |  |
| | Cytidine, 2'-deoxy-3-methyl- Chemical Properties |
| Boiling point | 429.4±55.0 °C(Predicted) | | density | 1.58±0.1 g/cm3(Predicted) | | pka | 13.95±0.60(Predicted) |
| | Cytidine, 2'-deoxy-3-methyl- Usage And Synthesis |
| Uses | 2’-Deoxy-N3-methylcytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | Cytidine, 2'-deoxy-3-methyl- Preparation Products And Raw materials |
|